Wegovy® (Semaglutide) Weight Loss Injection 2.4 mg / 0.75 mL

Description

Wegovy® (Semaglutide) Weight Loss Injection 2.4 mg / 0.75 mL. Wegovy contains semaglutide, a medication that belongs to the GLP-1 receptor agonist class. GLP-1 is a hormone your body naturally releases after eating to help control appetite and blood sugar. Wegovy works by mimicking this hormone, helping you feel full faster, stay satisfied longer, and reduce hunger throughout the day. As a result, many patients naturally eat less without feeling deprived, which supports steady and sustainable weight loss.

The 2.4 mg dose is the full maintenance dose of Wegovy and is typically reached after gradually increasing from lower strengths. This dose is intended for long-term use and provides consistent appetite control when paired with a reduced-calorie diet and regular physical activity.

Wegovy is taken once per week using a prefilled, single-use injection pen. It can be injected into the abdomen, thigh, or upper arm and may be taken with or without food. Choosing the same day each week helps maintain consistent results. The pen is designed for easy at-home use and does not require measuring or mixing.

In FDA-reviewed clinical trials, adults taking Wegovy lost an average of about 15% of their body weight over 68 weeks, with many patients noticing early weight loss within the first month. Individual results vary, but Wegovy has become one of the most prescribed medical weight loss injections in the U.S. due to its effectiveness and once-weekly convenience.

Wegovy is manufactured by Novo Nordisk and received FDA approval in 2021 for chronic weight management. It is not intended for cosmetic weight loss and should always be used under the supervision of a licensed healthcare provider.

Because Wegovy is temperature sensitive, it is classified as a refrigerated medication. Orders from Weight Loss RX ship using refrigerated, next-day delivery with signature required to ensure product safety. Prescription medications are non-returnable.

Some patients may experience side effects such as nausea, vomiting, diarrhea, constipation, or reduced appetite, especially when starting or increasing doses. These effects are usually temporary. Wegovy is not recommended for individuals with a personal or family history of medullary thyroid carcinoma (MTC), MEN 2, or for those who are pregnant or breastfeeding.

At Weight Loss RX, all Wegovy prescriptions are securely verified and dispensed in full compliance with U.S. pharmacy regulations.